Publications in collaboration with researchers from Complexo Hospitalario Universitario de Santiago (46)

2023

  1. Antifungal Combination Eye Drops for Fungal Keratitis Treatment

    Pharmaceutics, Vol. 15, Núm. 1

  2. Bringing lipidic lyotropic liquid crystal technology into biomedicine

    Trends in Pharmacological Sciences

  3. Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial

    Pharmaceutics, Vol. 15, Núm. 2

  4. Lipidic lyotropic liquid crystals: Insights on biomedical applications

    Advances in Colloid and Interface Science, Vol. 313

2022

  1. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  2. Evidencia seleccionada y cherry picking en formulación magistral

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 2, pp. 100-101

  3. Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery

    Pharmaceutics, Vol. 14, Núm. 4

  4. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

2021

  1. 3D printed tacrolimus suppositories for the treatment of ulcerative colitis

    Asian Journal of Pharmaceutical Sciences, Vol. 16, Núm. 1, pp. 110-119

  2. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10

  3. Characterization of new proteomic biomarker candidates in mucopolysaccharidosis type IVA

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-22

  4. Current Situation and Challenges in Vitreous Substitutes

    Macromolecular Bioscience, Vol. 21, Núm. 8

  5. Design, Optimization, and Characterization of Lactoferrin-Loaded Chitosan/TPP and Chitosan/Sulfobutylether-β-cyclodextrin Nanoparticles as a Pharmacological Alternative for Keratoconus Treatment

    ACS Applied Materials and Interfaces, Vol. 13, Núm. 3, pp. 3559-3575

  6. Design, development, and characterization of an idebenone-loaded poly-ε-caprolactone intravitreal implant as a new therapeutic approach for LHON treatment

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 168, pp. 195-207

  7. Development and characterization of a tacrolimus/ hydroxypropyl-β-cyclodextrin eye drop

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-27

  8. Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection

    Pharmaceutics, Vol. 13, Núm. 3

  9. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 162, pp. 12-22

  10. In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis

    International Journal of Pharmaceutics, Vol. 597

  11. Plasma proteomic analysis in morquio a disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 11

  12. Therapeutic drug monitoring of voriconazole: Validation of a high performance liquid chromatography method and comparison with an ARK immunoassay

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 3, pp. 154-159